- $144.29bn
- $189.39bn
- $63.63bn
- 98
- 83
- 77
- 98
Pfizer Inc - Regulatory Approval
AnnouncementPfizer Inc - New Data across Pfizers Pain and Inflammation Portfolio to Be Pres
AnnouncementPfizer Inc Pfizer Introduces New Treatment And Support Plan For Patients With Ov
AnnouncementPfizer Inc - Regulatory Approval
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Pfizer and Nektar Reach Agreement on Exubera(R)
AnnouncementPfizer Inc - Acquisition(s)
AnnouncementReplacement: Possible offer for AstraZeneca
Announcement$4.5 BILLION DEBT OFFERING
AnnouncementPFIZERS POSSIBLE OFFER FOR ASTRAZENECA PLC
AnnouncementPfizer Inc - Pfizer Enters into Research Consortium to Expand Understanding of D
AnnouncementPfizer Inc - Pfizers Lyrica Receives FDA Approval for Fibromyalgia Based on Exp
AnnouncementStatement re R&D Comments on Combination
AnnouncementRule 2.10 Announcement
AnnouncementPfizer Inc Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Impro
AnnouncementTHE BENEFITS OF A POTENTIAL COMBINATION
AnnouncementPfizer Inc - Two New Directors Elected to Pfizer Board
AnnouncementPfizer Inc - Canadian Court Finds Infringement of Lipitor Crystal Form Patent
AnnouncementPfizer Inc - Pfizer Declares a 32-Cent Second Quarter, 2008, Dividend
Announcement